Yes, hats off to those ladies for being willing to help science in this way. I'm not sure I'd have done it. I just hope it ended up giving them some benefit.
Thankfully, the company got the data and was able to end the trial early.
In Reply to 'PlentyParanoid' Maybe the difficulties in recruiting subjects had something to do with the fact that patients with relapsed platinum resistant ovarian cancer (meaning a really nasty cancer) were asked to wait a minimum of 3 weeks with mere BIOMARKER study BEFORE commencing salvage therapy.
I would hate to be in the recruiting doctor's shoes. And my hat goes high off for those unselfish individuals willing to shorten their already meager life-expectancies for science.
News 
Market Data 
Discover 
